Literature DB >> 20203643

Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.

Janus Ong, Zobair M Younossi.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Most patients with cryptogenic cirrhosis are considered to have had "burned out NAFLD." Although the recurrence and progression of NAFLD after liver transplantation (LT) have been shown previously, the incidence of de novo NAFLD after LT has not been extensively reported. In this issue of the American Journal of Gastroenterology, Dumortier et al. report the incidence of de novo post-LT NAFLD. Although most of the risk factors for post-LT NAFLD are similar to those for primary NAFLD, hepatic steatosis in the donor livers and a pre-transplant diagnosis of alcoholic liver disease remain independent risk factors. Although there are some limitations, this study provides the largest cohort of patients for whom post-LT NAFLD is reported.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203643     DOI: 10.1038/ajg.2009.720

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients.

Authors:  Milan Hájek; Monika Dezortová; Dita Wagnerová; Antonín Skoch; Luděk Voska; Irena Hejlová; Pavel Trunečka
Journal:  MAGMA       Date:  2011-07-10       Impact factor: 2.310

Review 2.  Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver.

Authors:  Jinyao Liu
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Quality of life 10 years after liver transplantation: The impact of graft histology.

Authors:  Vincent Karam; Mylène Sebagh; Kinan Rifai; Funda Yilmaz; Prashant Bhangui; Colette Danet; Faouzi Saliba; Didier Samuel; Denis Castaing; René Adam; Cyrille Feray
Journal:  World J Transplant       Date:  2016-12-24

4.  Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis.

Authors:  Sharma Love; Malik A Mudasir; Subhash C Bhardwaj; Gurdarshan Singh; Sheikh A Tasduq
Journal:  Oncotarget       Date:  2017-02-08

5.  Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.

Authors:  Pegah Golabi; Haley Bush; Maria Stepanova; Cameron T Locklear; Ira M Jacobson; Alita Mishra; Gregory Trimble; Madeline Erario; Chapy Venkatesan; Issah Younossi; Zachary Goodman; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.